During September 4-7 NBIX will open the books (a bit) about the ABT/NBIX Endometriosis drug which seems to be coming along very nicely in its last stage. So we should firming of the shares in the near future. Financially NBIX is also in fine fettle,
I am also long in ZLCS and PLX. PLX is likely to get FDA approval for Gaucher disease.FDA likes the product but wants to de sure there shouldnot be production problems such as with GENZ Check their message board to view good progress on this issue.